Stay updated with breaking news from Sight Stock Down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RxSight, Inc. (NASDAQ:RXST – Get Free Report) has earned a consensus rating of “Buy” from the seven brokerages that are currently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have updated their coverage on the stock in the last […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) COO Ilya Goldshleger sold 5,000 shares of the business’s stock in a transaction dated Monday, January 22nd. The stock was sold at an average price of $48.00, for a total value of $240,000.00. Following the sale, the chief operating officer now owns 26,475 shares in the company, valued […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) insider Eric Weinberg sold 10,000 shares of the stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $48.00, for a total transaction of $480,000.00. Following the completion of the sale, the insider now directly owns 309,978 shares in the company, […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) CFO Shelley B. Thunen sold 20,000 shares of RxSight stock in a transaction on Friday, December 15th. The shares were sold at an average price of $39.35, for a total value of $787,000.00. Following the completion of the transaction, the chief financial officer now owns 2,291 shares in […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report)’s share price was down 3.1% on Friday after an insider sold shares in the company. The stock traded as low as $27.22 and last traded at $27.26. Approximately 333,963 shares changed hands during trading, a decline of 9% from the average daily volume of 365,074 shares. The stock […]